Autologous Cellular Therapies: Defining the Scope and Obligations of Clinical Innovation A Research Symposium | Peatixtag:peatix.com,2011:12021-11-15T08:27:32+08:00PeatixTsung-Ling Autologous Cellular Therapies: Defining the Scope and Obligations of Clinical Innovation A Research Symposiumtag:peatix.com,2017:event-2332532017-05-24T08:30:00SGT2017-05-24T08:30:00SGTThis multi-disciplinary symposium is aimed at critically reflecting on the ethical, regulatory and conceptual issues surrounding the provision of autologous stem cells and cell-based products as ‘innovative therapies’. Interventions with autologous stem cells are being marketed directly to patients, typically over the Internet across geographical boundaries, for a wide range of serious illnesses and conditions. The global proliferation of these practices has raised concerns about the lack of scientific and clinical justification for these interventions and the possible harms they pose to patient populations vulnerable to exploitation. They have generally emerged from private clinics exploiting weaknesses in regulatory systems across different geographical jurisdictions and misinterpreting porous distinctions between clinical practice, research and innovation. They may also be indicative of a wider global trend to facilitate innovation by reducing legal and regulatory constraints over the use of novel medicines in the marketplace, rather than enabling more effective regulation, and demand critical attention to more clearly define the scope and obligations associated with responsible innovation.
The
symposium will focus on six original research papers with oral commentaries from
scholars with internationally-recognised expertise in the empirical, normative,
sociological and legal analysis of biomedical innovation, health technologies,
and stem cell science. Participants will include: Alastair Campbell; Centre for
Biomedical Ethics, NUS Sarah Chan: Usher Institute of
Population Health Sciences and Informatics, University of Edinburgh Christine Hauskeller; Department
of Sociology, Philosophy and Anthropology, University of Exeter Tereza Hendl; Centre for Values,
Ethics and the Law in Medicine, University of Sydney Wendy Lipworth; Centre for Values,
Ethics and the Law in Medicine, University of Sydney Tsung-Ling Lee; Centre for
Biomedical Ethics, NUS Dominique Martin; Faculty of
Health, Deakin University John Rasko; Centenary Institute of
Cancer Medicine & Cell Biology Douglas Sipp; Centre for Developmental
Biology, RIKEN Institute Jeremy Sugarman; Berman Institute
of Bioethics Leigh Turner; Centre for Bioethics,
University of Minnesota Catherine Waldby; ANU College of
Arts and Social SciencesCameron Stewart;
Sydney Law School, University of SydneyTamra Lysaght; Centre for
Biomedical Ethics, NUS
This event is supported with funding from the NUS
Humanities and Social Sciences Research Fund and is sponsored by the Stem Cell
Society, Singapore (SCSS).
Updatestag:peatix.com,2017-03-31 05:24:242017-03-31 05:24:24The event description was updated. Diff#236436Updatestag:peatix.com,2017-03-31 05:13:472017-03-31 05:13:47The event description was updated. Diff#236431Updatestag:peatix.com,2017-03-31 05:12:422017-03-31 05:12:42The event description was updated. Diff#236430Updatestag:peatix.com,2017-03-31 05:11:152017-03-31 05:11:15The event description was updated. Diff#236428Updatestag:peatix.com,2017-03-30 01:58:342017-03-30 01:58:34The event description was updated. Diff#236167Updatestag:peatix.com,2017-03-30 01:57:142017-03-30 01:57:14The event description was updated. Diff#236166Updatestag:peatix.com,2017-03-30 01:56:022017-03-30 01:56:02The event description was updated. Diff#236165Updatestag:peatix.com,2017-03-30 01:52:462017-03-30 01:52:46The event description was updated. Diff#236164Updatestag:peatix.com,2017-03-30 01:52:262017-03-30 01:52:26The event description was updated. Diff#236163